Colorectal Cancer
  • 數據庫收錄SCIE
  • 年發文量4

Colorectal Cancer

期刊中文名:結直腸癌ISSN:1758-194XE-ISSN:1758-1958

該雜志國際簡稱:COLORECTAL CANCER,是一本致力于發布--研究新成果的的專業學術期刊。主要發表刊登有創見的學術論文文章、行業最新科研成果,扼要報道階段性研究成果和重要研究工作的最新進展,選載對學科發展起指導作用的綜述與專論,促進學術發展,為廣大讀者服務。該刊是一本國際優秀雜志,在國際上有很高的學術影響力。

基本信息:
期刊簡稱:COLORECTAL CANCER
是否OA:未開放
是否預警:
Gold OA文章占比:71.43%
出版信息:
出版語言:English
評價信息:
JCR分區:Q3
影響因子:2.7
雜志介紹 JCR分區 CiteScore 投稿經驗

雜志介紹

Colorectal Cancer雜志介紹

《Colorectal Cancer》是一本以English為主的未開放獲取國際優秀期刊,中文名稱結直腸癌,本刊主要出版、報道領域的研究動態以及在該領域取得的各方面的經驗和科研成果,介紹該領域有關本專業的最新進展,探討行業發展的思路和方法,以促進學術信息交流,提高行業發展。該刊已被國際權威數據庫SCIE收錄,為該領域相關學科的發展起到了良好的推動作用,也得到了本專業人員的廣泛認可。該刊最新影響因子為2.7,

英文介紹

Colorectal Cancer雜志英文介紹

The Journal of Colorectal Cancer is an academic journal dedicated to the field of colorectal cancer research, covering various aspects of colorectal cancer, including etiology, pathogenesis, diagnosis, treatment, and prevention. This magazine provides a platform for medical researchers, clinical doctors, and healthcare professionals worldwide to share and exchange the latest research findings. The magazine also focuses on the prevention of colorectal cancer, emphasizing the reduction of incidence rate and mortality through screening, early diagnosis and lifestyle improvement. In addition, the magazine also discusses genetic factors, dietary habits, and other risk factors that may be associated with the occurrence of colorectal cancer.

Colorectal cancer, as the third most common cancer and the second deadliest cancer worldwide, poses a significant challenge to the health systems of many countries. Early diagnosis is crucial for reducing the mortality rate of colorectal cancer, as clinical symptoms often occur in the late stages of the disease. In addition to traditional colonoscopy, emerging minimally invasive methods such as liquid biopsy have also received widespread attention. The traditional methods for treating colorectal cancer include surgery, radiation therapy, and chemotherapy, but due to high mortality rates and disease recurrence issues, people are exploring new treatment methods such as targeted therapy, immunotherapy, and nanomedicine, some of which have entered the market and shown good results in clinical trials.

JCR分區(2023-2024年最新版)

Colorectal Cancer雜志 JCR分區信息

按JIF指標學科分區
學科:ONCOLOGY
收錄子集:ESCI
分區:Q3
排名:163 / 322
百分位:

49.5%

按JCI指標學科分區
學科:ONCOLOGY
收錄子集:ESCI
分區:Q4
排名:285 / 322
百分位:

11.65%

JCR分區:JCR分區來自科睿唯安公司,JCR是一個獨特的多學科期刊評價工具,為唯一提供基于引文數據的統計信息的期刊評價資源。每年發布的JCR分區,設置了254個具體學科。JCR分區根據每個學科分類按照期刊當年的影響因子高低將期刊平均分為4個區,分別為Q1、Q2、Q3和Q4,各占25%。JCR分區中期刊的數量是均勻分為四個部分的。

CiteScore 評價數據(2024年最新版)

Colorectal Cancer雜志CiteScore 評價數據

歷年影響因子和期刊自引率

投稿經驗

Colorectal Cancer雜志投稿經驗

該雜志是一本國際優秀雜志,在國際上有較高的學術影響力,行業關注度很高,已被國際權威數據庫SCIE收錄,該雜志在綜合專業領域專業度認可很高,對稿件內容的創新性和學術性要求很高,作為一本國際優秀雜志,一般投稿過審時間都較長,投稿過審時間平均 ,如果想投稿該刊要做好時間安排。版面費不祥。該雜志近兩年未被列入預警名單,建議您投稿。如您想了解更多投稿政策及投稿方案,請咨詢客服。

免責聲明

若用戶需要出版服務,請聯系出版商。

亚洲一区综合在线播放